Community-acquired pneumonia in older patients: Does age influence systemic cytokine levels in community-acquired pneumonia?

Respirology

Volumn 14, Issue 2, 2009, Pages 210-216

  Kelly, Emer ^a   MacRedmond, Ruth E ^a   Cullen, Garret ^a   Greene, Catherine M ^a   McElvaney, Noel G ^a   O'Neill, Shane J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Elderly; IL 10; IL 6; Immunology; Pneumonia

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; AGE DETERMINATION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BREATHING RATE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENESCENCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORAX PAIN; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD PRESSURE; BLOOD UREA NITROGEN; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY MECHANICS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 61349152991     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01423.x     Document Type: Article

References (25)

1. The British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q. J. Med. 1987 62 : 195 220.
2. Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996 51 : 1010 16.
3. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996 275 : 134 41.
4. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 1997 336 : 243 50.
5. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K et al. Lower serum concentrations of cytokines in elderly patients with pneumonia and impaired production of cytokines by peripheral blood monocytes in the elderly. Clin. Exp. Immunol. 1996 106 : 120 6.
6. Bruunsgaard H, Skinhoj P, Qvist J, Pedersen BK. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J. Infect. Dis. 1999 180 : 551 4.
7. Glynn P, Coakley R, Kilgallen I, Murphy N, O'Neill S. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999 54 : 51 5.
8. Lim WS, van der Ferden MM, Laing R, Boersma WG, Karalus N et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003 58 : 377 82.
9. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 1992 20 : 864 74.
10. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicentre study of 359 cases. Medicine 1990 69 : 307 16.
11. Marrie TJ. Epidemiology of community-acquired pneumonia in the elderly. Semin. Respir. Infect. 1990 5 : 260 8.
12. Foley SC, Kelly EM, O'Neill SJ. Audit of the management of patients admitted with community-acquired pneumonia. Ir. Med. J. 2006 99 : 138 40.
13. Harper C, Newton P. Clinical aspects of pneumonia in the elderly. J. Am. Geriatr. Soc. 1989 37 : 865 72.
14. Finkelstein MS, Petkun WM, Freedman ML, Antopol SC. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J. Am. Geriatr. Soc. 1983 31 : 19 27.
15. Zalacain R, Torres A, Celis R, Blanquer J, Aspa J et al. Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur. Respir. J. 2003 21 : 294 302.
16. Conte HA, Chen YT, Mehal W, Scinto JD, Quagliarello VJ. A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am. J. Med. 1999 106 : 20 8.
17. Moore AR, Clinch D. Underlying mechanism of impaired visceral pain perception in older people. J. Am. Geriatr. Soc. 2004 52 : 132 6.
18. Puren J, Feldman C, Savage N, Becker PJ, Smith C. Patterns of cytokine expression in community acquired pneumonia. Chest 1995 107 : 1342 9.
19. Yende S, D'Angelo G, Kellum JA, Weissfeld L, Fine J et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am. J. Respir. Crit. Care Med. 2008 177 : 1242 7.
20. Dehoux M, Boutten A, Ostinelli J, Seta N, Dombret MC et al. Compartmentalised cytokine production within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 1994 150 : 710 16.
21. Yende S, Toumanen EI, Wunderink R, Kanaya A, Newman AB et al. Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am. J. Respir. Crit. Care Med. 2005 172 : 1440 6.
22. Antunes G, Evans SA, Lordan JL, Frew AJ. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur. Respir. J. 2002 20 : 990 5.
23. Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am. J. Med. 2004 117 (Suppl. 9A 5S 11S.
24. Fernandez-Serrano S, Dorca J, Coromines M, Carratala J, Gudiol F et al. Molecular inflammatory responses measured in blood of patients with severe community acquired pneumonia. Clin. Diagn. Lab. Immunol. 2003 10 : 813 20.
25. Metersky ML, Ma A, Bratzler DW, Houck PM. Predicing bacteremia in patients with community acquired pneumonia. Am. J. Respir. Crit. Care Med. 2004 169 : 342 7.